Firmonertinib has the potential to redefine first-line treatment in this underserved population as a once daily, oral, brain-penetrant, chemo-free monotherapy ALPACCA pivotal trial is designed to ...
NEWTOWN SQUARE, Pa., Dec. 22, 2025 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc. (Company or ArriVent) (Nasdaq: AVBP), a clinical-stage company dedicated to accelerating the global development of ...
With a second consecutive disastrous season, the Browns desperately need to sell hope to their battered fan base. Yes, it’s early, but Shedeur Sander appears to be just that. I believe the fastest ...
Key milestone achieved as Company advances clinical program to full approval trial of ateganosine sequenced with a checkpoint inhibitor in comparison to chemotherapy CHICAGO, Dec. 11, 2025 (GLOBE ...
MUNICH & SAN FRANCISCO, December 02, 2025--(BUSINESS WIRE)--CatalYm today announced that the first patient has been dosed in the randomized Phase 2b GDFATHER‑NSCLC‑02 (GDF‑15 ...
Washington’s youth movement up front has certainly been notable. The Huskies opened the season with true freshman offensive lineman John Mills as their starting left guard. Injuries have created ...
Physics and Python stuff. Most of the videos here are either adapted from class lectures or solving physics problems. I really like to use numerical calculations without all the fancy programming ...
President Donald Trump said Tuesday that he would dismiss U.S. military leaders immediately if he found them unsuitable, adding tension to civil-military relations ahead of a high-profile gathering of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback